California lawmakers are moving forward with Assembly Bill 2365, aimed at regulating kratom products sold in the state. This legislation seeks to establish health and safety standards for kratom, a plant native to Southeast Asia that has gained popularity for its stimulant and sedative effects, depending on dosage. Proponents argue that the bill is essential to protect consumers from potentially dangerous, unregulated products, especially as California accounts for nearly 25% of all kratom sales in the U.S.

During a recent government meeting, advocates highlighted the risks associated with kratom, including dependency and overdose. David Breger, a parent who lost his son to a kratom overdose, passionately urged lawmakers to pass the bill, emphasizing the need for regulations to prevent further tragedies. He criticized the lack of federal oversight and called for immediate action to safeguard public health.

Dr. Aaron Berthold, a kratom researcher, echoed these sentiments, noting the rapid increase in kratom use in the U.S. and the need for regulations to ensure product safety. He pointed out that traditional consumption methods differ significantly from the concentrated products available in the U.S., which can pose health risks.

While the bill has garnered support from various law enforcement and health organizations, some opposition has emerged regarding specific provisions. Critics argue that a proposed limit on hydroxymitragynine, a potent alkaloid in kratom, may be too restrictive and could hinder access for individuals using kratom to manage pain or opioid withdrawal symptoms. They suggest a higher allowable percentage to ensure efficacy while still maintaining safety.

The bill's author, Assemblymember Haney, defended the 1% limit as based on current scientific understanding and consistent with regulations in other states. He expressed openness to further discussions with stakeholders to refine the legislation.

As the bill progresses, it aims to create a regulatory framework that balances consumer safety with access to kratom's potential benefits, addressing a growing public health concern in California. The committee voted in favor of the bill, which will now move to the appropriations committee for further consideration.